415 related articles for article (PubMed ID: 15641059)
1. Differential matrix degradation and turnover in early cartilage lesions of human knee and ankle joints.
Aurich M; Squires GR; Reiner A; Mollenhauer JA; Kuettner KE; Poole AR; Cole AA
Arthritis Rheum; 2005 Jan; 52(1):112-9. PubMed ID: 15641059
[TBL] [Abstract][Full Text] [Related]
2. The pathobiology of focal lesion development in aging human articular cartilage and molecular matrix changes characteristic of osteoarthritis.
Squires GR; Okouneff S; Ionescu M; Poole AR
Arthritis Rheum; 2003 May; 48(5):1261-70. PubMed ID: 12746899
[TBL] [Abstract][Full Text] [Related]
3. Matrix homeostasis in aging normal human ankle cartilage.
Aurich M; Poole AR; Reiner A; Mollenhauer C; Margulis A; Kuettner KE; Cole AA
Arthritis Rheum; 2002 Nov; 46(11):2903-10. PubMed ID: 12428230
[TBL] [Abstract][Full Text] [Related]
4. Collagen and proteoglycan turnover in focally damaged human ankle cartilage: evidence for a generalized response and active matrix remodeling across the entire joint surface.
Aurich M; Mwale F; Reiner A; Mollenhauer JA; Anders JO; Fuhrmann RA; Kuettner KE; Poole AR; Cole AA
Arthritis Rheum; 2006 Jan; 54(1):244-52. PubMed ID: 16388531
[TBL] [Abstract][Full Text] [Related]
5. Turnover of type II collagen and aggrecan in cartilage matrix at the onset of inflammatory arthritis in humans: relationship to mediators of systemic and local inflammation.
Fraser A; Fearon U; Billinghurst RC; Ionescu M; Reece R; Barwick T; Emery P; Poole AR; Veale DJ
Arthritis Rheum; 2003 Nov; 48(11):3085-95. PubMed ID: 14613270
[TBL] [Abstract][Full Text] [Related]
6. Differences in type II collagen turnover of osteoarthritic human knee and ankle joints.
Aurich M; Hofmann GO; Rolauffs B
Int Orthop; 2017 May; 41(5):999-1005. PubMed ID: 28168551
[TBL] [Abstract][Full Text] [Related]
7. Changes in joint cartilage aggrecan after knee injury and in osteoarthritis.
Lohmander LS; Ionescu M; Jugessur H; Poole AR
Arthritis Rheum; 1999 Mar; 42(3):534-44. PubMed ID: 10088777
[TBL] [Abstract][Full Text] [Related]
8. Aggrecan degradation in human cartilage. Evidence for both matrix metalloproteinase and aggrecanase activity in normal, osteoarthritic, and rheumatoid joints.
Lark MW; Bayne EK; Flanagan J; Harper CF; Hoerrner LA; Hutchinson NI; Singer II; Donatelli SA; Weidner JR; Williams HR; Mumford RA; Lohmander LS
J Clin Invest; 1997 Jul; 100(1):93-106. PubMed ID: 9202061
[TBL] [Abstract][Full Text] [Related]
9. Expression of Sox9 and type IIA procollagen during attempted repair of articular cartilage damage in a transgenic mouse model of osteoarthritis.
Salminen H; Vuorio E; Säämänen AM
Arthritis Rheum; 2001 Apr; 44(4):947-55. PubMed ID: 11315934
[TBL] [Abstract][Full Text] [Related]
10. Chondrocyte matrix metalloproteinase-8: up-regulation of neutrophil collagenase by interleukin-1 beta in human cartilage from knee and ankle joints.
Chubinskaya S; Huch K; Mikecz K; Cs-Szabo G; Hasty KA; Kuettner KE; Cole AA
Lab Invest; 1996 Jan; 74(1):232-40. PubMed ID: 8569187
[TBL] [Abstract][Full Text] [Related]
11. Increased type II collagen degradation and very early focal cartilage degeneration is associated with upregulation of chondrocyte differentiation related genes in early human articular cartilage lesions.
Tchetina EV; Squires G; Poole AR
J Rheumatol; 2005 May; 32(5):876-86. PubMed ID: 15868625
[TBL] [Abstract][Full Text] [Related]
12. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic cartilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1).
Dahlberg L; Billinghurst RC; Manner P; Nelson F; Webb G; Ionescu M; Reiner A; Tanzer M; Zukor D; Chen J; van Wart HE; Poole AR
Arthritis Rheum; 2000 Mar; 43(3):673-82. PubMed ID: 10728762
[TBL] [Abstract][Full Text] [Related]
13. Cartilage biomarkers in ankylosing spondylitis: relationship to clinical variables and treatment response.
Kim TH; Stone M; Payne U; Zhang X; Ionescu M; Lobanok T; King L; Poole AR; Inman RD
Arthritis Rheum; 2005 Mar; 52(3):885-91. PubMed ID: 15751093
[TBL] [Abstract][Full Text] [Related]
14. Uncoupling of type II collagen synthesis and degradation predicts progression of joint damage in patients with knee osteoarthritis.
Garnero P; Ayral X; Rousseau JC; Christgau S; Sandell LJ; Dougados M; Delmas PD
Arthritis Rheum; 2002 Oct; 46(10):2613-24. PubMed ID: 12384919
[TBL] [Abstract][Full Text] [Related]
15. Expression of matrix metalloproteinases in normal and damaged articular cartilage from human knee and ankle joints.
Chubinskaya S; Kuettner KE; Cole AA
Lab Invest; 1999 Dec; 79(12):1669-77. PubMed ID: 10616215
[TBL] [Abstract][Full Text] [Related]
16. Repeated intraarticular injections of triamcinolone acetonide alter cartilage matrix metabolism measured by biomarkers in synovial fluid.
Céleste C; Ionescu M; Robin Poole A; Laverty S
J Orthop Res; 2005 May; 23(3):602-10. PubMed ID: 15885481
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis.
Matyas JR; Atley L; Ionescu M; Eyre DR; Poole AR
Arthritis Rheum; 2004 Feb; 50(2):543-52. PubMed ID: 14872497
[TBL] [Abstract][Full Text] [Related]
18. Human knee and ankle cartilage explants: catabolic differences.
Eger W; Schumacher BL; Mollenhauer J; Kuettner KE; Cole AA
J Orthop Res; 2002 May; 20(3):526-34. PubMed ID: 12038627
[TBL] [Abstract][Full Text] [Related]
19. Increased collagen and aggrecan degradation with age in the joints of Timp3(-/-) mice.
Sahebjam S; Khokha R; Mort JS
Arthritis Rheum; 2007 Mar; 56(3):905-9. PubMed ID: 17328064
[TBL] [Abstract][Full Text] [Related]
20. Role of interleukin-1 and tumor necrosis factor alpha in matrix degradation of human osteoarthritic cartilage.
Kobayashi M; Squires GR; Mousa A; Tanzer M; Zukor DJ; Antoniou J; Feige U; Poole AR
Arthritis Rheum; 2005 Jan; 52(1):128-35. PubMed ID: 15641080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]